Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1959 1
1966 1
1975 1
1978 1
1986 1
1996 1
1997 1
1999 1
2001 2
2002 4
2003 2
2004 4
2005 4
2006 7
2007 20
2008 27
2009 13
2010 1
2011 3
2012 2
2013 1
2015 1
2016 1
2017 2
2019 1
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 18166738

99 results
Results by year
Filters applied: . Clear all
Page 1
Corticosteroids and erythropoeitin-receptor agonists.
McLachlan CS. McLachlan CS. CMAJ. 2008 Jan 1;178(1):66. doi: 10.1503/cmaj.1070144. CMAJ. 2008. PMID: 18166738 Free PMC article. No abstract available.
Efficacy and safety of epoetin alfa in critically ill patients.
Corwin HL, Gettinger A, Fabian TC, May A, Pearl RG, Heard S, An R, Bowers PJ, Burton P, Klausner MA, Corwin MJ; EPO Critical Care Trials Group. Corwin HL, et al. N Engl J Med. 2007 Sep 6;357(10):965-76. doi: 10.1056/NEJMoa071533. N Engl J Med. 2007. PMID: 17804841 Free article. Clinical Trial.
Relative mortality and epoetin alpha dose among hemodialysis patients.
Coyne DW. Coyne DW. Am J Kidney Dis. 2008 May;51(5):866-7; author reply 867. doi: 10.1053/j.ajkd.2008.01.028. Am J Kidney Dis. 2008. PMID: 18436101 No abstract available.
Relative mortality and epoetin alpha dose in hemodialysis patients.
Cotter DJ, Thamer M, Zhang Y. Cotter DJ, et al. Am J Kidney Dis. 2008 May;51(5):865; author reply 865-6. doi: 10.1053/j.ajkd.2007.12.045. Am J Kidney Dis. 2008. PMID: 18436099 No abstract available.
Randomized, double-blind, placebo-controlled trial of epoetin alfa in men with castration-resistant prostate cancer and anemia.
Winquist E, Julian JA, Moore MJ, Nabid A, Sathya J, Wood L, Venner P, Levine M. Winquist E, et al. J Clin Oncol. 2009 Feb 1;27(4):644-6. doi: 10.1200/JCO.2008.20.4966. Epub 2008 Dec 22. J Clin Oncol. 2009. PMID: 19103725 Clinical Trial. No abstract available.
Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials.
Zarychanski R, Turgeon AF, McIntyre L, Fergusson DA. Zarychanski R, et al. CMAJ. 2007 Sep 25;177(7):725-34. doi: 10.1503/cmaj.071055. Epub 2007 Sep 5. CMAJ. 2007. PMID: 17823140 Free PMC article.
Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
Wizemann V, Rutkowski B, Baldamus C, Scigalla P, Koytchev R; Epoetin Zeta Study Group. Wizemann V, et al. Curr Med Res Opin. 2008 Mar;24(3):625-37. doi: 10.1185/030079908X273264. Curr Med Res Opin. 2008. PMID: 18208642 Clinical Trial.
Anemia and response to epoetin alfa: the cause of anemia matters!
Dharmarajan TS. Dharmarajan TS. J Am Geriatr Soc. 2008 Aug;56(8):1574-5. doi: 10.1111/j.1532-5415.2008.01776.x. J Am Geriatr Soc. 2008. PMID: 18808607 No abstract available.
Pharmacokinetic and pharmacodynamic research in the intensive care unit: an unmet need.
Haas CE, Forrest A. Haas CE, et al. Crit Care Med. 2006 Jun;34(6):1831-3. doi: 10.1097/01.CCM.0000219372.32810.20. Crit Care Med. 2006. PMID: 16714989 No abstract available.
Targeting anemia with erythropoietin during critical illness.
Cook D, Crowther M. Cook D, et al. N Engl J Med. 2007 Sep 6;357(10):1037-9. doi: 10.1056/NEJMe078150. N Engl J Med. 2007. PMID: 17804850 No abstract available.
99 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback